The journal of obstetrics and gynaecology research · 2019
Postoperative pain control with ropivacaine following laparoscopic myomectomy: A randomized double-blind, pilot study.
СтатьяРандомизированное исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kwack Jae Young, Ahn Kwang Hee, Kwon Yong-Soon
Аннотация
AIM: The aim of this study was to evaluate immediate pain control in patients who underwent laparoscopic myomectomy (LM) by intraoperative injection of ropivacaine into both uterosacral ligaments.
METHODS: The study was a prospective, double-blind, randomized study. We analyzed 46 cases of LM performed between July 2015 and November 2016 by a single surgeon. We randomized the enrolled patients into either a ropivacaine or a saline injection group. Before the surgeon closed the abdominal wall, each 7.5% ropivacaine (5 mL) or saline (5 mL) was administered into both uterosacral ligaments through laparoscopic injection needle. We compared the pain intensity scores 2, 6, 12, and 24 h after injection between the two groups.
RESULTS: The pain intensity scores were not significantly different. However, the ropivacaine group requested less of the analgesic than the placebo-injected group requested (P = 0.035). No patient in the ropivacaine group reported any side effects.
CONCLUSION: Intraoperative ropivacaine injection into both uterosacral ligaments during LM can reduce the dosage of opioid analgesics.
METHODS: The study was a prospective, double-blind, randomized study. We analyzed 46 cases of LM performed between July 2015 and November 2016 by a single surgeon. We randomized the enrolled patients into either a ropivacaine or a saline injection group. Before the surgeon closed the abdominal wall, each 7.5% ropivacaine (5 mL) or saline (5 mL) was administered into both uterosacral ligaments through laparoscopic injection needle. We compared the pain intensity scores 2, 6, 12, and 24 h after injection between the two groups.
RESULTS: The pain intensity scores were not significantly different. However, the ropivacaine group requested less of the analgesic than the placebo-injected group requested (P = 0.035). No patient in the ropivacaine group reported any side effects.
CONCLUSION: Intraoperative ropivacaine injection into both uterosacral ligaments during LM can reduce the dosage of opioid analgesics.